Navigation Links
Monsanto's Industry-Leading Seed Position Creates Accelerated Biotech Trait Opportunity in Latin America
Date:6/5/2008

2008 Accomplishments Provide Continuing Springboard for Growth in 2009 and

Beyond

NEW YORK, June 5 /PRNewswire-FirstCall/ -- Monsanto's international seed brands serve as an ideal launching pad that positions the company for new launches of biotechnology traits with significant scale and ramp-up speed, Brett Begemann, Monsanto's executive vice president of global commercial, will tell investors today at the Merrill Lynch Agricultural Chemicals Conference in New York.

Begemann will cite the examples of Argentina and Brazil, where the company recently received separate regulatory approvals for corn biotechnology traits. In Argentina, Monsanto received the first-ever approval for a double-stack trait combination, YieldGard Corn Borer with Roundup Ready Corn 2, and plans to offer the combination on more than 1 million acres in its year of introduction. Likewise, Monsanto received planting approval for the YieldGard Corn Borer trait in Brazil and is planning for a 1 million to 2 million acre launch for the upcoming 2008-2009 season.

"If you combine the scale of our seed businesses in Argentina and Brazil with our proven ability to deliver traits, we're in the best competitive position to enter new trait markets quickly and with an immediate financial benefit," said Begemann. "These two approvals came a year ahead of our original plan, accelerating this opportunity and giving us what we believe is a significant first-mover advantage that translates to an enduring advantage in these new markets."

Begemann's comments will be part of a broader update on the company's five-year growth plan, which targets doubling the company's 2007 gross profit by 2012. With the company's third quarter just completed, Begemann will indicate that the company's 2008 progress on its six identified growth drivers continues to set the stage for further growth in 2009 and beyond. Monsanto will report its third-quarter earnings on June 25, and will provide further strategic updates at that point.

At today's conference, Begemann will highlight developments in key areas of the company's growth drivers. These include:

-- U.S. corn business: With U.S. planting nearing completion, Monsanto

remains on track with its 2-3 share point gains in its DEKALB corn

seed business and complementary 1-2 share point gains in its American

Seeds, Inc. businesses. Paired with increased trait penetration,

especially for triple stacks, Monsanto is setting the stage for the

introduction of its new SmartStax trait platform for corn expected in

2010, Begemann said.

-- International corn: In addition to the new biotech trait launches in

Latin America, Monsanto has strengthened its corn seed position in its

key international markets. Notably, in Argentina, Monsanto brands

have gained 5 shares points, ahead of the original expectation of 1-2

share point gain. In Brazil, where Monsanto targeted holding share in

2008, its seed brands met the objective and are poised for growth in

2009. In expanding markets in the European Union and India, Monsanto

brands fell short of the original 1-2 share-point gain target, but

retain strong positions and good momentum for renewed growth in 2009.

-- Soybeans: Monsanto remains on target for its planned 1 million to 2

million acre pre-commercial launch of its Roundup Ready 2 Yield

platform in 2009 in the United States, with significant seed bulk up

and final commercial testing underway in 2008 to support the roll out

next year.

-- Cotton: In the United States, Monsanto's cotton business continues to

be a turnaround story, with the Deltapine seed brand expected to lose

share in 2008 and stabilize at a level of approximately 33-36 percent.

With new seed varieties in testing and a more aggressive trait ramp-up

program, Monsanto is re-establishing the base for renewed growth in

the Deltapine brand.

Begemann will emphasize that Monsanto's growth will continue to come from innovation, with a focus on developing new products and technology that create value for farmers and the value chain by improving the productivity of acres that are being farmed.

"What I believe we do better than anyone else is to apply our technology to increase on-farm yields," said Begemann. "As a leading technology provider in agriculture, our products work to create more grain at a lower cost with less risk to serve the collective needs for feed, food and fuel across crops."

Webcast Information

Begemann's presentation slides and simultaneous audio webcast of the presentation may be accessed by visiting the company's web site at http://www.monsanto.com/investors. Following today's live broadcast set for 2 p.m. ET, a replay of the webcast will be available for two weeks through this same link.

Monsanto Company is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality. For more information on Monsanto, see: http://www.monsanto.com/.

Cautionary Statements Regarding Forward-Looking Information:

Certain statements contained in this release are "forward-looking statements," such as statements concerning the company's anticipated financial results, current and future product performance, regulatory approvals, business and financial plans and other non-historical facts. These statements are based on current expectations and currently available information. However, since these statements are based on factors that involve risks and uncertainties, the company's actual performance and results may differ materially from those described or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, among others: continued competition in seeds, traits and agricultural chemicals; the company's exposure to various contingencies, including those related to intellectual property protection, regulatory compliance and the speed with which approvals are received, and public acceptance of biotechnology products; the success of the company's research and development activities; the outcomes of major lawsuits; developments related to foreign currencies and economies; successful operation of recent acquisitions; fluctuations in commodity prices; compliance with regulations affecting our manufacturing; the accuracy of the company's estimates related to distribution inventory levels; the company's ability to fund its short-term financing needs and to obtain payment for the products that it sells; the effect of weather conditions, natural disasters and accidents on the agriculture business or the company's facilities; and other risks and factors detailed in the company's most recent periodic report to the SEC. Undue reliance should not be placed on these forward-looking statements, which are current only as of the date of this release. The company disclaims any current intention or obligation to update any forward-looking statements or any of the factors that may affect actual results.

Note to editor: DEKALB, Deltapine, SmartStax, Roundup Ready, and Roundup Ready 2 Yield are trademarks of Monsanto Company and its wholly owned subsidiaries.


'/>"/>
SOURCE Monsanto Company
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Sureshield Coatings Company Established to Market Industry-Leading Portfolio of Advanced Coatings for Metal Surfaces
2. Halogen Customers Shape Industry-Leading Employee Performance and Talent Management Solution
3. Human Pheromone Sciences Enters Into Agreement to Reposition and Promote its Natural Attraction(R) Brand
4. Jack Anthony to Resign From VaxGens Board After Accepting CEO Position at Osprey Pharmaceuticals
5. Ceregene Appoints Joao Siffert, M.D. to the Position of Chief Medical Officer
6. Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology
7. Transgene: Cash Position of EUR 119 Million as of September 30, 2007
8. Easily Lift, Transfer and Reposition Patients with Ground-Breaking Liftaem(TM) System from Smart Medical Technology, Inc.
9. ADVENTRX Announces Consolidation of Clinical and Management Positions
10. LS9, Inc., the Renewable Petroleum Company(TM), Adds Key Positions to Executive Team and Scientific Advisory Board
11. Cephalon General Counsel John E. Osborn to Resign Position
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... ... (TDR) procedures can be safely completed in an ambulatory surgery center (ASC) with ... (ACDF) procedures and previous two-year TDR studies. , Jake Lubinski, president of ...
(Date:2/24/2017)... ... February 24, 2017 , ... Chef Jodi Abel has returned from her ... several cities, she gained a number of delicious recipes and new techniques to share ... South Africa’s Western Cape province. It is internationally renowned for its incredible wine ...
(Date:2/24/2017)... 2017  Aethlon Medical, Inc. (Nasdaq: AEMD ... Chairman and CEO, Jim Joyce . ... last Saturday, Bill Gates warned world leaders ... than nuclear weapons. Mr. Gates expressed his concern, which ... that scientific terrorists have access to the necessary tools ...
(Date:2/24/2017)... 2017  Driven by consumers, preference towards more ... fastest growing categories, finds the recently published U.S. ... Care: Multi-regional Market Analysis and Opportunities study ... Kline. "Biotechnology actives are derived from ... effective for skin and hair care applications," explains ...
Breaking Biology Technology:
(Date:2/26/2017)... , Feb. 25, 2017  Securus Technologies, a ... solutions for public safety, investigation, corrections and monitoring, ... and Reentry. "Too often, too many ... and county jails are trying to tackle this ... and friends and family members. While significant steps are ...
(Date:2/21/2017)... LONDON , February 21, 2017 ... um 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr ... es einige Hindernisse zu überwinden gilt, um diese Prognose ... ... unter anderem die Mobilisierung der finanziellen Mittel für die ...
(Date:2/13/2017)... , Feb. 13, 2017 Former 9/11 Commission ... Judiciary Committee, Janice Kephart of Identity Strategy ... Donald Trump,s "Executive Order: Protecting the Nation ... 27, 2017):  "As President Trump,s ,Travel Ban, ... has now essentially banned the travel ban, it is ...
Breaking Biology News(10 mins):